This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

reputable news agency

proofread

Canada approves updated COVID vaccine for fall

flu shot
Credit: Unsplash/CC0 Public Domain

Canada on Tuesday approved an updated Moderna COVID vaccine targeting new variants, and is reviewing others likely to be rolled out this fall to mitigate infections once more on the rise.

This comes after the United States on Monday approved Moderna and Pfizer vaccines that correspond to an Omicron sublineage.

"I know we all wish COVID-19 no longer existed," Health Canada's chief medical advisor Supriya Sharma told a news conference in Ottawa.

"But people are still getting infected and vaccination continues to be one of the most effective ways to protect ourselves against serious outcomes including , hospitalization and death," she said.

"Receiving a shot of the new formulation will help protect people against the variants circulating currently and expected to circulate through the fall and winter."

The updated Moderna vaccine specifically targets the Omicron XBB.1.5 subvariant and has been approved for people six months of age and older.

Sharma said Pfizer-BioNTech's revised vaccine, as well as a proposal for an updated shot from Novavax are also "being reviewed on a priority basis."

Most Canadians have had at least two doses of a COVID vaccine, but the protection wanes over time. Only a small number have gotten boosters so far this year.

After a bad 2022-2023 respiratory virus season that saw a combination of influenza, COVID and RSV () cases overwhelm hospitals, said they are now hoping to see more people roll up their sleeves for flu and COVID shots in the coming months.

© 2023 AFP

Citation: Canada approves updated COVID vaccine for fall (2023, September 12) retrieved 2 May 2024 from https://medicalxpress.com/news/2023-09-canada-covid-vaccine-fall.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

EU drug watchdog approves updated Pfizer Covid jab

2 shares

Feedback to editors